CRISPRi-mediated repression of efflux pumps reveals Rv1258c as a key contributor to pyrazinamide resistance in Mycobacterium tuberculosis.

Publication date: Jun 19, 2025

Concepts Keywords
Drugs Contributor
Mycobacterium Crispri
Pumps Drugs
Rv1258c Edinb
Tuberculosis Efflux
Key
Mediated
Mycobacterium
Pumps
Pyrazinamide
Repression
Resistance
Reveals
Tuberculosis

Semantics

Type Source Name
disease MESH repression
drug DRUGBANK Pyrazinamide

Original Article

(Visited 11 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *